Consumption of fish wards off kidney damage in diabetics

According to a recent stud eating at least two servings of fish each week wards of decline of kidneys in diabetics. The study was conducted on more than 22,000 adults in England.

The study was published in the American Journal of Kidney Diseases, the official journal of the National Kidney Foundation. It mentions that fish consumption lowers abnormal levels of protein in the urine in people with diabetes.

Folic Acid and Vitamin B6, B12 Supplements do not offer Lowered Cancer Risk

Researchers at Brigham and Women's Hospital and Harvard Medical School have found that supplements of folic acid, vitamins B6 and B12 neither reduce nor increase the risk of breast or other invasive cancers in women.

Experimental Drug Burns Fat Even on a High-Fat Diet

A team of French scientists has said that they have discovered a fat burning drug that "tricks the body into burning off fat," even while on a high fat diet. The drug, called SRT1720 has so far only been successfully tested on mice by a team of scientists at the University of Louis Pasteur.

Mylan gets nod to market UCB’s epilepsy drug

Mylan Inc., the biggest US maker of generic drugs, has informed that it has received approval to market a generic version of Levetiracetam Tablets.

The company said that Food and Drug Administration has approved its application to market generic versions of the drug, also called Levetiracetam, in 250 milligram, 500 mg and 750 mg tablets.

Levetiracetam Tablets are the generic version of UCB Pharma's Keppra, which is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 4 years of age and older with epilepsy.

Cardiovascular System to merge with Replidyne

Cardiovascular Systems Inc. (CSI) has entered into a definitive merger agreement under which CSI will merge with Struggling biotech company Replidyne Inc in an all-stock merger valued at up to $40 million.

CSI is a medical device company focused on developing and commercializing interventional treatment systems for vascular disease.

Pages

News in Focus

Chinese government aiming at 1 million FCEV registrations by 2030

According to a report by the South China Morning Post, the Chinese government is aiming for an ambitious target of getting 1 million fuel cell vehicles (FCEVs) on the roads by the year 2030.

VW ID.3 special edition, limited to 30,000 units, is out of stock

In a recent statement released shortly ahead of the upcoming IAA event this week, German automaker Volkswagen (VW) has revealed that its limited special edition of the ID.3 is now out of stock.

Porsche unveils final production version of ‘Taycan’ all-electric car

German automaker Porsche officially unveiled the final production version its first all-electric car -- the ‘Taycan’ -- on Wednesday, September 4, 2019.

BMW to discontinue hybrid i8 production by April 2020

In a recent press release, German automaker BMW has indicated that it will stop producing its i8 plug-in hybrid sports car from April 2020.

Fraunhofer ISE develops EV solar roof with highly efficient solar cells

Germany-based Fraunhofer Institute for Solar Energy Systems (Fraunhofer ISE) has developed solar roofing for electric vehicles (EVs), in an apparent effort to increase their driving range.

CNH Industrial invests $250M in e-truck start-up Nikola

In a recent statement, UK-headquartered capital goods company CNH Industrial has revealed that it is making a $250-million investment in US startup Nikola, which specializes in the production of el

Evergrande cooperates with Benteler and FEV to advance its EV plans

According to Chinese media reports, the country’s renowned real estate group Evergrande is cooperating with two German companies to advance its ambitious electric vehicle (EV) plans.